'Profound' success in treating children, young adults with rare blood disorders

Hematology researchers have safely and effectively treated children and young adults for autoimmune blood disorders in a multicenter clinical trial. In children with one of those conditions, autoimmune lymphoproliferative syndrome, all the patients showed a durable, complete response, with normal blood cell counts and rapid improvements, a result the study team called 'profound.'

from Today's Healthcare News -- ScienceDaily http://ift.tt/1N5km4w